Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users
- 1 November 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (17) , 2311-2316
- https://doi.org/10.1097/00002030-200111230-00013
Abstract
To assess whether initiation of highly active antiretroviral therapy (HAART) is associated with a subsequent resumption of sexual and drug use risk behaviors. Within an ongoing prospective study of HIV-seropositive injection drug users (IDUs), a subsample with at least one CD4 cell count 6 Of 316 eligible HIV-seropositive IDUs, 133 reported HAART use during the study period; 95% were African American, 76% were male, and median age at enrollment was 34 years. The proportion who reported any sexual activity increased over time from 55 to 61% for the HAART-treated group, but decreased from 67 to 63% in the untreated group (P = 0.03); the respective values for unprotected sex were 18 versus 20% and 36 versus 28% (P = 0.06). In both treated and untreated groups, the proportion injecting drugs declined (P = 0.04), whereas the proportion reporting needle sharing decreased marginally (P = 0.11). However, trends in use of shooting galleries between the groups differed (P = 0.04) increasing slightly from 2.3 to 3% in the treated group while decreasing from 12 to 5% in the untreated group. In persons treated with HAART, self-report of high-risk behaviors remained stable or showed some increase. Persons initiating HAART should be counselled to refrain from high-risk behaviors.Keywords
This publication has 15 references indexed in Scilit:
- Antiretroviral Therapy in AdultsJAMA, 2000
- Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men.Health Psychology, 2000
- Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection DurationJAMA, 1998
- Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease InhibitorsNew England Journal of Medicine, 1998
- Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sexAIDS, 1998
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- Prognostic Indicators for AIDS and Infectious Disease Death in HIV-Infected Injection Drug UsersJAMA, 1998
- Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention.Health Psychology, 1998
- HIV-1 protease inhibitors. A review for cliniciansJAMA, 1997
- Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USAPublished by American Medical Association (AMA) ,1996